Your browser doesn't support javascript.
loading
The Patient Journey in Facial Aesthetics: Findings from a European Consensus Meeting on Improving the Quality of Life for Patients Receiving Botulinum Toxin Injections.
Philipp-Dormston, Wolfgang G; De Boulle, Koenraad; Gronovich, Yoav; Lowe, Nick; Sayed, Karim; Sykianakis, Dimitrios; Tuncer, Serhan.
Afiliação
  • Philipp-Dormston WG; Hautzentrum Köln, Cologne, Germany.
  • De Boulle K; Faculty of Health, University Witten/Herdecke, Witten, Germany.
  • Gronovich Y; Aalst Dermatology Clinic, Aalst, Belgium.
  • Lowe N; Department of Plastic and Reconstructive Surgery, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Sayed K; University of Manchester, Manchester, UK.
  • Sykianakis D; University of California, Los Angeles School of Medicine, Los Angeles, CA, USA.
  • Tuncer S; Nomi Oslo Clinic, Oslo, Norway.
Clin Cosmet Investig Dermatol ; 17: 329-337, 2024.
Article em En | MEDLINE | ID: mdl-38327550
ABSTRACT

Purpose:

Successful treatment of facial lines with botulinum toxin is largely dependent on patient satisfaction; thus, a structured treatment journey that uses patient-reported outcomes (PROs) is helpful for maximizing botulinum toxin results. To develop a patient-centric approach for botulinum toxin injections in facial aesthetics, a group of clinicians met to provide opinions on an optimal treatment journey that uses PROs to quantify treatment benefits on patient quality of life. Patients and

Methods:

A multidisciplinary panel of 9 clinicians with expertise in facial aesthetic procedures convened for an advisory board that was preceded by and followed up with a structured, multistep consensus discussion. Based on current literature, the panel's expertise, structured questions, and group discussion, panelists assessed, reconciled, and agreed upon on a patient journey for botulinum toxin treatment in facial aesthetics.

Results:

Panelists agreed that an optimal patient journey includes screening, assessment, treatment, posttreatment, and follow-up visits. A compact, easy-to-complete, and digital PRO questionnaire should be provided before the visit. During screening, thorough assessments are integral for a successful patient journey because they provide an opportunity to understand treatment goals, address patient concerns, discuss risks and benefits, obtain medication lists/medical history, and take pretreatment photographs. Treatment strategies should include discussing and educating on the approach/choice of botulinum toxin and ensuring patients are comfortable. Posttreatment, clinicians should request intense muscle movements to enhance product uptake and be available to address patient concerns. Finally, during follow-up, PRO questionnaires can be provided to gauge patient satisfaction with treatment, and pretreatment photographs can be provided to allow patients to track their progression. Follow-ups should be scheduled with new patients or those reporting low satisfaction.

Conclusion:

Establishing a relationship, being aware of the patient's goals, and developing an individualized care plan allows for a structured, patient-centered treatment journey that promotes positive aesthetic outcomes.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research Idioma: En Ano de publicação: 2024 Tipo de documento: Article